Cargando…
JC Virus-DNA Detection Is Associated with CD8 Effector Accumulation in Peripheral Blood of Patients with Multiple Sclerosis under Natalizumab Treatment, Independently from JC Virus Serostatus
Although natalizumab (anti-α4 integrin) represents an effective therapy for relapsing remitting multiple sclerosis (RRMS), it is associated with an increased risk of developing progressive multifocal leukoencephalopathy (PML), caused by the polyomavirus JC (JCV). The aim of this study was to explore...
Autores principales: | Zingaropoli, Maria A., Iannetta, Marco, Pontecorvo, Simona, Anzivino, Elena, Prezioso, Carla, Rodio, Donatella Maria, Morreale, Manuela, D'Abramo, Alessandra, Oliva, Alessandra, Lichtner, Miriam, Cortese, Antonio, Frontoni, Marco, Pietropaolo, Valeria, Francia, Ada, Mastroianni, Claudio M., Vullo, Vincenzo, Ciardi, Maria R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848061/ https://www.ncbi.nlm.nih.gov/pubmed/29682547 http://dx.doi.org/10.1155/2018/5297980 |
Ejemplares similares
-
Human polyomavirus JC replication and non-coding control region analysis in multiple sclerosis patients under natalizumab treatment
por: Pietropaolo, Valeria, et al.
Publicado: (2015) -
HIV-associated progressive multifocal leukoencephalopathy: longitudinal study of JC virus non-coding control region rearrangements and host immunity
por: Iannetta, Marco, et al.
Publicado: (2013) -
Natalizumab Affects T-Cell Phenotype in Multiple Sclerosis: Implications for JCV Reactivation
por: Iannetta, Marco, et al.
Publicado: (2016) -
Diagnostic Value of JC Polyomavirus Viruria, Viremia, Serostatus and microRNA Expression in Multiple Sclerosis Patients Undergoing Immunosuppressive Treatment
por: Prezioso, Carla, et al.
Publicado: (2022) -
JC virus detection and JC virus-specific immunity in natalizumab-treated Multiple Sclerosis patients
por: Mancuso, Roberta, et al.
Publicado: (2012)